Sorin Group and Cyberonics merged company to be known as LivaNova

Sorin S.p.A., a global medical device company and a leader in the treatment of cardiovascular diseases, and Cyberonics, Inc. a medical device company with core expertise in neuromodulation, unveiled LivaNova as the name of their combined company, effective at the close of their proposed merger.LivaNova will operate as three business units: Cardiac Surgery, Cardiac Rhythm Management and Neuromodulation, with operating headquarters in Mirandola (Italy), Clamart (France) and Houston (U.S.) respectively. The company will have a presence in over 100 countries around the world with approximately 4,500 employees.Until the closing of the transaction, both companies will continue to operate separately under their current brand names and leadership structures. As previously announced, the transaction is expected to be completed by the end of the third calendar quarter of 2015